The American Journal of Medicine
Volume 123, Issue 7 , Pages 593-595 , July 2010

Office Management after Myocardial Infarction

  • Wilbert S. Aronow, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Wilbert S. Aronow, MD, FACC, FAHA, Cardiology Division, New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595

References 

  1. Smith SC, Allen J, Blair SN, et al. ACC/AHA guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363–2372
  2. 2003 Joint National Committee. The Seventh Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). JAMA. 2003;289:2560–2572
  3. HOPE (Heart Outcomes Prevention Evaluation) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–153
  4. Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease (A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention). Circulation. 2007;115:2761–2788
  5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22
  6. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
  7. Ades PA. Exercise training and cardiac rehabilitation in older cardiac patients. In:  Aronow WS,  Fleg JL,  Rich MW editor. Cardiovascular Disease in the Elderly. Fourth edition. New York City: Informa Healthcare; 2008;p. 405–417
  8. Smith SC, Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update (A statement for healthcare professionals from the American Heart Association and the American College of Cardiology). J Am Coll Cardiol. 2001;38:1581–1583
  9. Aronow WS, Frishman WH. Angina in the elderly. In:  Aronow WS,  Fleg J,  Rich MW editor. Cardiovascular Disease in the Elderly. Fourth edition. New York City: Informa Healthcare; 2008;p. 269–292
  10. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction (An overview of results from randomized controlled trials). JAMA. 1993;270:1589–1595
  11. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 1997;349:667–674
  12. Kennedy HL, Brooks MM, Barker AH, et al. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol. 1994;74:674–680
  13. Aronow WS, Ahn C, Mercando AD, et al. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%. Am J Cardiol. 1994;74:267–270
  14. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576–1583
  15. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  16. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol. 2006;48:1498–1502
  17. Holmes DR, Singh M. Percutaneous coronary intervention in the elderly. In:  Aronow WS,  Fleg J,  Rich MW editor. Cardiovascular Disease in the Elderly. Fourth edition. New York City: Informa Healthcare; 2008;p. 387–404
  18. Stemmer EA, Aronow WS. Surgical management of coronary artery disease in the elderly. In:  Aronow WS,  Fleg J,  Rich MW editor. Cardiovascular Disease in the Elderly. Fourth edition. New York City: Informa Healthcare; 2008;p. 351–385

 Funding: None.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00286-X

doi: 10.1016/j.amjmed.2010.02.011

The American Journal of Medicine
Volume 123, Issue 7 , Pages 593-595 , July 2010

Article Tools